Hanmi Pharmaceutical

OverviewSuggest Edit

Hanmi Pharmaceutical is a company focused on the development and commercialization of pharmaceutical products. It develops treatments for diabetes, obesity, cancer, autoimmune, and rare diseases.
TypePublic
Founded1973
Websitehanmipharm.com
Employee Ratings3.6

Latest Updates

Employees (est.) (Dec 2019)2,444
Share Price (Jun 2021)₩327.5 K
Cybersecurity ratingBMore

Hanmi Pharmaceutical Financials and Metrics

Hanmi Pharmaceutical Revenue

Market capitalization (16-Jun-2021)

3.9t

Closing stock price (16-Jun-2021)

327.5k
Hanmi Pharmaceutical's current market capitalization is ₩3.9 t.
Show all financial metrics

Hanmi Pharmaceutical Cybersecurity Score

Cybersecurity ratingPremium dataset

B

84/100

SecurityScorecard logo

Hanmi Pharmaceutical Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

40-49

out of 100

CSRHub logo

Hanmi Pharmaceutical Online and Social Media Presence

Embed Graph

Hanmi Pharmaceutical Frequently Asked Questions

  • When was Hanmi Pharmaceutical founded?

    Hanmi Pharmaceutical was founded in 1973.

  • How many employees does Hanmi Pharmaceutical have?

    Hanmi Pharmaceutical has 2,444 employees.

  • Who are Hanmi Pharmaceutical competitors?

    Competitors of Hanmi Pharmaceutical include Alembic Pharmaceuticals, Biocon and Cipla.